Long Non-coding RNA LINC00968 Attenuates Drug Resistance of Breast Cancer Cells Through Inhibiting the Wnt2/β-catenin Signaling Pathway by Regulating WNT2

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2019 Feb 23

PMID 30791958

Citations 37

Authors

Dian-Hui Xiu

Gui-Feng Liu

Shao-Nan Yu

Long-Yun Li

Guo-Qing Zhao

Lin Liu

Xue-Feng Li

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is one the most common cancers, making it the second leading cause of cancer-related death among women. Long non-coding RNAs (lncRNAs), with tightly regulated expression patterns, also serve as tumor suppressor during tumorigenesis. The present study aimed to elucidate the role of LINC00968 in breast cancer via WNT2-mediated Wnt2/β-catenin signaling pathway.

Methods: Breast cancer chip GSE26910 was utilized to identify differential expression in LINC00968 and WNT2. The possible relationship among LINC00968, transcriptional repressor HEY and WNT2 was analyzed and then verified. Effects of LINC00968 on activation of the Wnt2/β-catenin signaling pathway was also tested. Drug resistance, colony formation, cell migration, invasion ability and cell apoptosis after transfection were also determined. Furthermore, tumor xenograft in nude mice was performed to test tumor growth and weight in vivo.

Results: WNT2 expression exhibited at a high level, whereas LINC00968 at a low expression in breast cancer which was also associated with poor prognosis in patients. LINC00968 targeted and negatively regulated WNT2 potentially via HEY1. Either overexpressed LINC00968 or silenced inhibited activation of the Wnt2/β-catenin signaling pathway, thereby reducing drug resistance, decreasing colony formation ability, as well as suppressing migration and invasion abilities of breast cancer cells in addition to inducing apoptosis. Lastly, in vivo experiment suggested that LINC00968 overexpression also suppressed transplanted tumor growth in nude mice.

Conclusion: Collectively, overexpressed LINC00968 contributes to reduced drug resistance in breast cancer cells by inhibiting the activation of the Wnt2/β-catenin signaling pathway through silencing WNT2. This study offers a new target for the development of breast cancer treatment.

Citing Articles

Prognostic Value and Immune Landscapes of Four Types of RNA Modification Writer-Related LncRNAs Signature in Lung Adenocarcinoma.

Qian Y, Zhang Q, Ren Y, Cao L, Zheng S, Li B J Cancer. 2024; 15(15):4818-4837.

PMID: 39132150 PMC: 11310873. DOI: 10.7150/jca.96755.

High Expression Confers Poor Prognosis in Colorectal Cancer, and Represents a Novel Therapeutic Target in BRAF-Mutated Colorectal Cancer.

Liu H, Zhang L, Wang Y, Wu R, Shen C, Li G Medicina (Kaunas). 2023; 59(6).

PMID: 37374338 PMC: 10301164. DOI: 10.3390/medicina59061133.

Signaling pathways involved in the biological functions of dendritic cells and their implications for disease treatment.

Cheng H, Chen W, Lin Y, Zhang J, Song X, Zhang D Mol Biomed. 2023; 4(1):15.

PMID: 37183207 PMC: 10183318. DOI: 10.1186/s43556-023-00125-3.

Landscape of NcRNAs involved in drug resistance of breast cancer.

Kang Y Clin Transl Oncol. 2023; 25(7):1869-1892.

PMID: 37067729 PMC: 10250522. DOI: 10.1007/s12094-023-03189-3.

Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.

Kashyap D, Sharma R, Goel N, Buttar H, Garg V, Pal D Front Genet. 2023; 13:993687.

PMID: 36685962 PMC: 9852779. DOI: 10.3389/fgene.2022.993687.

References

DeSantis C, Fedewa S, Sauer A, Kramer J, Smith R, Jemal A . Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2015; 66(1):31-42. DOI: 10.3322/caac.21320. View

Chen Y, Liu Y, Wei H, Lv K, Fu P . Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumour Biol. 2016; 37(8):10861-70. DOI: 10.1007/s13277-016-4909-1. View

Zhao X, Qu J, Sun Y, Wang J, Liu X, Wang F . Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget. 2017; 8(18):30576-30586. PMC: 5444766. DOI: 10.18632/oncotarget.15736. View

Runowicz C, Leach C, Henry N, Henry K, Mackey H, Cowens-Alvarado R . American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2015; 66(1):43-73. DOI: 10.3322/caac.21319. View

Xu H, Tian Y, Yuan X, Liu Y, Wu H, Liu Q . Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. Onco Targets Ther. 2016; 9:431-44. PMC: 4727509. DOI: 10.2147/OTT.S97192. View

Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q . lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res. 2014; 13(2):330-8. PMC: 4336811. DOI: 10.1158/1541-7786.MCR-14-0251. View

Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang J . Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget. 2016; 7(16):22159-73. PMC: 5008352. DOI: 10.18632/oncotarget.8063. View

Wang Y, Zhou J, Xu Y, Hu H . Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway. J Cell Physiol. 2017; 233(4):3397-3406. DOI: 10.1002/jcp.26186. View

Xu S, Kong D, Chen Q, Ping Y, Pang D . Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017; 16(1):129. PMC: 5525255. DOI: 10.1186/s12943-017-0696-6. View

10.

Sun J, Chen X, Wang Z, Guo M, Shi H, Wang X . A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sci Rep. 2015; 5:16553. PMC: 4637883. DOI: 10.1038/srep16553. View

11.

Yang Y, Wei L, Zhang Y, Hayano T, Pineiro Pereda M, Nakaoka H . Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis. Clin Exp Metastasis. 2018; 35(3):109-121. DOI: 10.1007/s10585-018-9901-2. View

12.

Tracy K, Tye C, Ghule P, Malaby H, Stumpff J, Stein J . Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer. Mol Cancer Res. 2018; 16(4):587-598. PMC: 5882506. DOI: 10.1158/1541-7786.MCR-17-0548. View

13.

Li D, Chen W, Luo L, Wang Y, Shang J, Zhang Y . Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation. Int J Mol Med. 2017; 40(6):1895-1906. DOI: 10.3892/ijmm.2017.3187. View

14.

Fu L, Zhang C, Zhang L, Dong S, Lu L, Chen J . Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut. 2011; 60(12):1635-43. DOI: 10.1136/gut.2011.241638. View

15.

Li N, Li S, Wang Y, Wang J, Wang K, Liu X . Decreased expression of WNT2 in villi of unexplained recurrent spontaneous abortion patients may cause trophoblast cell dysfunction via downregulated Wnt/β-catenin signaling pathway. Cell Biol Int. 2017; 41(8):898-907. DOI: 10.1002/cbin.10807. View

16.

Xia X, Yu Y, Zhang L, Ma Y, Wang H . Inhibitor of DNA binding 1 regulates cell cycle progression of endothelial progenitor cells through induction of Wnt2 expression. Mol Med Rep. 2016; 14(3):2016-24. PMC: 4991734. DOI: 10.3892/mmr.2016.5491. View

17.

Williams H, Mill C, Monk B, Hulin-Curtis S, Johnson J, George S . Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration. Arterioscler Thromb Vasc Biol. 2016; 36(7):1417-24. DOI: 10.1161/ATVBAHA.116.307626. View

18.

Kimura M, Nakajima-Koyama M, Lee J, Nishida E . Transient Expression of WNT2 Promotes Somatic Cell Reprogramming by Inducing β-Catenin Nuclear Accumulation. Stem Cell Reports. 2016; 6(6):834-843. PMC: 4911497. DOI: 10.1016/j.stemcr.2016.04.012. View

19.

Zhang H, Xue J, Li M, Zhao X, Wei D, Li C . Metformin regulates stromal-epithelial cells communication via Wnt2/β-catenin signaling in endometriosis. Mol Cell Endocrinol. 2015; 413:61-5. DOI: 10.1016/j.mce.2015.06.011. View

20.

Fujita A, Sato J, Rodrigues L, Ferreira C, Sogayar M . Evaluating different methods of microarray data normalization. BMC Bioinformatics. 2006; 7:469. PMC: 1636075. DOI: 10.1186/1471-2105-7-469. View